Hempstreet, with a focus on cannabis, secures millions in funding for its bags.

Hempstreet 1.0, a health technology startup specializing in cannabis, has successfully raised $1 million in its pre-Series A funding round. The company intends to utilize the newly acquired capital to diversify its product offerings, intensify clinical trials for exclusive formulations, and venture into international markets.

Established in 2019 by Abhishekmo, HempStreet focuses on producing cannabis-derived medications tailored for various health issues, including digestive ailments, menstrual cramps, sexual health, hypertension, and anxiety.